An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain
- PMID: 35312946
- PMCID: PMC9127021
- DOI: 10.1007/s40744-022-00431-2
An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain
Abstract
Introduction: Using data from patients residing in Salford, UK, we aimed to compare healthcare resource utilisation (HCRU) and direct healthcare costs between patients with moderate to severe (M-S) or severe osteoarthritis (OA) pain and those without OA.
Methods: Patients with a M-S OA pain event within a period of chronic pain were indexed from the Salford Integrated Record (SIR) between 2010 and 2017. Patients with a severe pain event formed an OA subcohort. Patients in each OA pain cohort were independently matched to patients without OA, forming two control cohorts. HCRU, prescribed analgesic drugs, and total direct costs per UK standardised tariffs were calculated for the year post-index. Multivariable models were used to identify drivers of healthcare cost.
Results: The M-S OA pain and control cohorts each comprised 3123 patients; the severe OA pain and control cohorts each comprised 1922 patients. Patients in both OA pain cohorts had a significantly higher mean number of general practitioner encounters, inpatient, outpatient, and accident and emergency visits, and were prescribed a broader range of analgesic drugs in the year post-index than respective controls. Mean healthcare costs of all types were significantly higher in the M-S and severe OA pain cohorts vs controls (total: M-S £2519 vs £1379; severe £3389 vs £1397). Paracetamol (M-S: 40% of patients had at least one prescription; severe: 50%) and strong opioids (34% and 59%) were the analgesics most prescribed to patients with OA pain. In all cohorts, multivariable models showed that a higher age at index, the presence of gout, osteoporosis, type 2 diabetes, or coronary artery disease, significantly contributed towards higher healthcare costs.
Conclusion: In the population of Salford, UK, patients with M-S OA pain had significantly higher annual HCRU and costs compared with matched controls without OA; generally, these were even higher in patients with severe OA pain.
Keywords: Analgesia; Arthroplasty; Chronic pain; England; Healthcare cost; Hospitalisation; Length of stay; Osteoarthritis; Primary health care; Regional health planning.
© 2022. The Author(s).
Figures
References
-
- The Economist Intelligence Unit, Sayburn S. The unrecognised burden of osteoarthritis: unmet needs in Europe. 2021. https://cdn.vev.design/private/BCwBc9ZFZyVz8yQQKr9VeLxSnjf1/d6Jx2OYBUF_U.... Accessed 18 Oct 2021.
-
- Belsey J. Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care. J Med Econ. 2002;5(1–4):39–50. doi: 10.3111/200205039050. - DOI
-
- Public Health England. Musculoskeletal health: 5 year prevention strategic framework. A statement of PHE, NHS England and Versus Arthritis' commitments to promote musculoskeletal health and to prevent musculoskeletal conditions. 2019 (last update 20 Jun 2019). https://www.gov.uk/government/publications/musculoskeletal-health-5-year.... Accessed 18 Oct 2021.
-
- Public Health England. Chronic pain in adults 2017. An analysis of self-reported chronic pain from 2017 Health Survey for England data. 2020 (last update 4 Jun 2021). https://www.gov.uk/government/publications/chronic-pain-in-adults-2017. Accessed 18 Oct 2021.
LinkOut - more resources
Full Text Sources
